Novo Nordisk President & CEO Mike Doustdar discusses the recent US approval of Novo Nordisk's Wegovy weight loss pill, the advantage of being the first to market, the availability of the pill, the company's gameplan, and the timeline of the pill's release. Doustdar spoke with Bloomberg's Katie Greifeld.

Chevron CEO Mike Wirth Talks Venezuela JV, Hormuz Flows
10:44

US Energy Secretary Chris Wright Talks Venezuela Oil Production
10:14

Hatch CEO Ann Crady Weiss Talks New Hatch Sleep Clock & Sleep Tech
10:42